Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16731-37-6

Post Buying Request

16731-37-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16731-37-6 Usage

Chemical structure

The compound consists of a uracil base attached to a β-D-erythro-pentofuran-3-ulosyl sugar molecule, which is protected by two trityl groups.

Protection

The trityl groups provide protection to the sugar molecule, allowing for selective modification or manipulation of the compound in synthetic processes.

Application

1-<2,5-di-O-trityl-β-D-erythro-pentofuran-3-ulosyl>uracil is commonly used in the synthesis of nucleosides and nucleotides.

Research

The compound is also used in the study of nucleic acid structure and function.

Specific structure

Its unique structure and reactivity make it a valuable building block in the production of pharmaceuticals and biologically active molecules.

Synthetic utility

The compound's structure allows for the creation of various derivatives with potential applications in medicinal chemistry and drug development.

Stability

The presence of trityl groups enhances the stability of the compound, making it more suitable for use in chemical reactions and synthesis processes.

Solubility

The compound is likely to be soluble in organic solvents, such as chloroform or methanol, due to the presence of the trityl groups.

Purity

The compound can be synthesized with high purity, which is essential for its use in research and pharmaceutical applications.

Analytical techniques

Techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry can be used to analyze and confirm the structure of 1-<2,5-di-O-trityl-β-D-erythro-pentofuran-3-ulosyl>uracil.

Check Digit Verification of cas no

The CAS Registry Mumber 16731-37-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,3 and 1 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 16731-37:
(7*1)+(6*6)+(5*7)+(4*3)+(3*1)+(2*3)+(1*7)=106
106 % 10 = 6
So 16731-37-6 is a valid CAS Registry Number.

16731-37-6Relevant articles and documents

Synthesis of Uridine Derivatives Containing Strategically Placed Radical Traps as Potential Inhibitors of Ribonucleotide Reductase

Auguste, Sandra P.,Young, Douglas W.

, p. 395 - 404 (2007/10/02)

A series of uridine derivatives have been prepared with a view to inhibiting the enzyme ribonucleotide reductase by trapping the radical responsible for initiating the reduction.These have an oxime ether on the beta face at C-3 or C-2 of the ribose moiety

Synthesis and Anticancer and Antiviral Activities of Various 2'- and 3'-Methylidene-Substituted Nucleoside Analogues and Crystal Structure of 2'-Deoxy-2'-methylidenecytidine Hydrochloride

Lin, Tai-Shun,Luo, Mei-Zhen,Liu, Mao-Chin,Clarke-Katzenburg, Regina H.,Cheng, Yung-Chi,et al.

, p. 2607 - 2615 (2007/10/02)

Various 2'- and 3'-methylidene-substituted nucleoside analogues have been synthesized and evaluated as potential anticancer and/or antiviral agents.Among these compounds, 2'-deoxy-2'-methylidene-5-fluorocytidine (22) and 2'-deoxy-2'-methylidenecytidine (23) not only demonstrated potent anticancer activity in culture against murine L1210 and P388 leukemias, Sarcoma 180, and human CCRF-CEM lymphoblastic leukemia, producing ED50 values of 1.2 and 0.3 μM, 0.6 and 0.4 μM, 1.5 and 1.5 μM, and 0.05 and 0.03 μM, respectively, but also were active in mice against murine L1210 leukemia.Of all the tested drug dosage levels (25, 50, and 75 mg/kg, respectively) compound 23 had no toxic deaths and compound 22 yielded only one toxic death at the highest dosage level.On the contrary, in the same study, 1-β-D-arabinofuranosylcytosine (ara-C) resulted in 2/5, 5/5, and 5/5 toxic deaths, respectively.Both compounds 22 and 23 have shown better anticancer activity than ara-C, yielding higher T/C * 100 values and some long-term survivors ( > 60 days).In addition, compounds 22 and 23 were found to have, respectively, approximately 130 and 40 times lower binding affinity for cytidine/deoxycytidine deaminase derived from human KB cells compared to ara-C, suggesting that the two 2'-methylidene-substituted analogues may be more resistant to deamination.Cytoplasmic deoxycytidine kinase (dCK) was required for compounds 22 and 23 action.Furthermore, compounds 14, 22, 23, and 24 also have antiherpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) activity in cell culture.In addition, the crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride (23*HCl) was determined by X-ray crystallography.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16731-37-6